Please assess the completion status of the following clinical trial:

Trial Title: In Vivo Efficacy Study of Patient Preoperative Preps

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects of any race~* Subjects in good health~* Minimum skin flora baseline requirements on abdomen and groin~Exclusion Criteria:~* Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin disorders (including acne) on the applicable test area~* Topical antimicrobial exposure within 14 days prior to screening and treatment days~* Use of systemic or topical antibiotics, steroid medications, or any other products known to affect the normal microbial flora of the skin within 14 days prior to screening and treatment days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 3M CHG/IPA Prep C (Type: EXPERIMENTAL): Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
- 3M CHG/IPA Prep CH (Type: EXPERIMENTAL): Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
- ChloraPrep (Type: ACTIVE_COMPARATOR): Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.
- Normal Saline (Type: PLACEBO_COMPARATOR): Apply topically for 30 seconds to the abdominal region or 2 minutes to the inguinal region, and allow to dry for 3 minutes.

Based on this trial design, predict the completion outcome and termination type (if applicable).